Efficacy and tolerability. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases37

Drug-Related Side Effects and Adverse Reactions Nausea Nasopharyngitis Neoplasms Gastrointestinal Diseases Vomiting Recurrence Pain Headache Breast Neoplasms Migraine Disorders Flushing Disease Progression Epilepsy Neoplasm Metastasis Disease Models, Animal Malaria, Falciparum Lung Neoplasms HIV Infections Fatigue Neutropenia Neoplasm Recurrence, Local Flatulence Acute Disease Urinary Bladder, Overactive Diarrhea Dizziness Acne Vulgaris Erectile Dysfunction Chronic Disease Exanthema Hypertension Anorexia Constipation Colorectal Neoplasms Fever Leukopenia

Chemicals and Drugs134

Placebos Drug Combinations Delayed-Action Preparations Antineoplastic Agents Anticonvulsants Triazoles Dermatologic Agents Piracetam Indans Deoxycytidine Artemisinins Fluorenes Antimalarials Anti-Inflammatory Agents, Non-Steroidal Ethanolamines Antibodies, Monoclonal, Humanized Antibodies, Monoclonal Cathartics Tablets Polyethylene Glycols Thiophenes Taxoids Diclofenac Antipsychotic Agents Isoxazoles Ointments Piperazines Quinolines Quinolones Antihypertensive Agents Anti-Bacterial Agents Sulfonamides Fluorouracil Capsules Oxycodone Sulfones Paclitaxel Tryptamines Pyrimidines Pyridines Antiviral Agents Mefloquine Benzimidazoles Nitriles Piperidines Thiazoles Amodiaquine Pyrroles Cyclohexanols Antidepressive Agents, Second-Generation Benzodiazepines Naproxen Phenylurea Compounds Quinazolines Interferon-alpha Ophthalmic Solutions Serotonin Uptake Inhibitors Protein Kinase Inhibitors Immunosuppressive Agents Benzenesulfonates Hydrochlorothiazide Antimetabolites, Antineoplastic Organoplatinum Compounds Dipyrone Indoles Gastrointestinal Agents Antidepressive Agents Prodrugs Anti-Infective Agents Anti-Inflammatory Agents Angiogenesis Inhibitors Acetamides Anti-HIV Agents Antifungal Agents Polysorbates Niacinamide Antidepressive Agents, Tricyclic Antirheumatic Agents Thiazines Cisplatin Nasal Sprays Aromatase Inhibitors Pyrazoles Recombinant Proteins Muscarinic Antagonists Methotrexate Benzamides Doxorubicin Propylamines Triazines Anti-Infective Agents, Local Bisacodyl Antineoplastic Agents, Phytogenic Leucovorin Analgesics, Opioid Ritonavir Camptothecin Bronchodilator Agents Drugs, Investigational Antiemetics Plant Extracts Bridged Compounds Ribavirin Cholinesterase Inhibitors Dosage Forms Azithromycin Moclobemide Ibuprofen Tetrazoles Imidazoles Oxazolidinones Cyclooxygenase Inhibitors Analgesics, Non-Narcotic Dibenzothiazepines Azetidines Immunologic Factors Keratolytic Agents Piroxicam Carboplatin Antineoplastic Agents, Hormonal Pyrimethamine Pyridones Cyclobutanes Carbamates Amlodipine Risperidone Metformin Citalopram Vinblastine Carbamazepine Chlorobenzenes Purines Emollients Gels

Analytical, Diagnostic and Therapeutic Techniques and Equipment62

Treatment Outcome Double-Blind Method Drug Administration Schedule Administration, Oral Drug Therapy, Combination Placebos Delayed-Action Preparations Area Under Curve Antineoplastic Combined Chemotherapy Protocols Maximum Tolerated Dose Prospective Studies Randomized Controlled Trials as Topic Infusions, Intravenous Clinical Trials as Topic Follow-Up Studies Single-Blind Method Cross-Over Studies Pilot Projects Injections, Subcutaneous Severity of Illness Index Pain Measurement Injections, Intramuscular Injections, Intravenous Disease-Free Survival Combined Modality Therapy Retrospective Studies Feasibility Studies Administration, Topical Survival Analysis Administration, Inhalation Survival Rate Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Phytotherapy Drug Evaluation Product Surveillance, Postmarketing Administration, Cutaneous Administration, Sublingual Disease Models, Animal Drug Delivery Systems Treatment Failure Drug Evaluation, Preclinical Analysis of Variance Chronotherapy Administration, Intravenous Neoplasm Staging Blood Pressure Dosage Forms Drug Substitution Kaplan-Meier Estimate Dry Powder Inhalers Remission Induction Early Termination of Clinical Trials Research Design Chemotherapy, Adjuvant Xenograft Model Antitumor Assays Metabolic Clearance Rate Therapeutic Irrigation Vaccination Controlled Clinical Trials as Topic Hypodermoclysis Administration, Intranasal

Psychiatry and Psychology6

Pain Patient Compliance Medication Adherence Depressive Disorder, Major Erectile Dysfunction Psychiatric Status Rating Scales

Phenomena and Processes16

Dose-Response Relationship, Drug Drug Tolerance Area Under Curve Maximum Tolerated Dose Time Factors Drug Interactions Half-Life Pain Biological Availability Therapeutic Equivalency Blood Pressure Drug Resistance, Neoplasm Food-Drug Interactions Drug Synergism Metabolic Clearance Rate Drug Resistance

Disciplines and Occupations2

Chemistry, Pharmaceutical Research Design

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture2

Polyethylene Glycols Polysorbates

Humanities1

Quality of Life

Information Science1

Named Groups2

Healthy Volunteers Patient Dropouts

Health Care30

Treatment Outcome Double-Blind Method Safety Area Under Curve Prospective Studies Randomized Controlled Trials as Topic Clinical Trials as Topic Follow-Up Studies Single-Blind Method Cross-Over Studies Pilot Projects Severity of Illness Index Disease-Free Survival Retrospective Studies Feasibility Studies Patient Compliance Survival Analysis Survival Rate Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Treatment Failure Analysis of Variance Patient Satisfaction Drug Substitution Kaplan-Meier Estimate Medication Adherence Early Termination of Clinical Trials Placebo Effect Vaccination Controlled Clinical Trials as Topic

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care

Treatment Outcome Double-Blind Method Drug Administration Schedule Dose-Response Relationship, Drug Administration, Oral Drug Therapy, Combination Placebos Drug Combinations Delayed-Action Preparations Drug Tolerance Safety Area Under Curve Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Maximum Tolerated Dose Time Factors Prospective Studies Randomized Controlled Trials as Topic Infusions, Intravenous Drug-Related Side Effects and Adverse Reactions Clinical Trials as Topic Nausea Follow-Up Studies Single-Blind Method Anticonvulsants Triazoles Dermatologic Agents Cross-Over Studies Piracetam Pilot Projects Nasopharyngitis Injections, Subcutaneous Indans Deoxycytidine Artemisinins Fluorenes Severity of Illness Index Neoplasms Gastrointestinal Diseases Antimalarials Anti-Inflammatory Agents, Non-Steroidal Ethanolamines Pain Measurement Antibodies, Monoclonal, Humanized Injections, Intramuscular Antibodies, Monoclonal Cathartics Healthy Volunteers Tablets Polyethylene Glycols Thiophenes Injections, Intravenous Drug Interactions Taxoids Diclofenac Antipsychotic Agents Isoxazoles Ointments Piperazines Quinolines Quinolones Antihypertensive Agents Anti-Bacterial Agents Vomiting Sulfonamides Fluorouracil Capsules Oxycodone Disease-Free Survival Recurrence Combined Modality Therapy Retrospective Studies Sulfones Feasibility Studies Half-Life Paclitaxel Tryptamines Pain Administration, Topical Patient Compliance Pyrimidines Pyridines Headache Antiviral Agents Mefloquine Benzimidazoles Survival Analysis Breast Neoplasms Nitriles Migraine Disorders Piperidines Thiazoles Amodiaquine Pyrroles Flushing Cyclohexanols Administration, Inhalation Biological Availability Antidepressive Agents, Second-Generation Benzodiazepines

No FAQ available that match "efficacy and tolerability"